Basic Information
APRINOIA Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing highly sensitive and selective diagnostic and therapeutic agents for a wide range of neurodegenerative diseases.
APRINOIA Therapeutics Inc
Boston,Massachusetts,United States of America
15~50 people
May 20, 2015
contact@aprinoia.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios